|
VPS26A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.982700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.754200E-02 |
| Normal-vs-Stage2 |
4.989600E-02 |
| Normal-vs-Stage3 |
2.084300E-02 |
| Normal-vs-Stage4 |
3.852200E-02 |
| Stage1-vs-Stage2 |
4.352000E-01 |
| Stage1-vs-Stage3 |
6.049400E-01 |
| Stage1-vs-Stage4 |
5.765400E-01 |
| Stage2-vs-Stage3 |
7.139400E-01 |
| Stage2-vs-Stage4 |
8.494400E-01 |
| Stage3-vs-Stage4 |
8.774000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.998100E-03 |
| Normal-vs-AfricanAmerican |
6.511200E-01 |
| Normal-vs-Asian |
2.724800E-01 |
| Caucasian-vs-AfricanAmerican |
2.822600E-01 |
| Caucasian-vs-Asian |
4.179400E-01 |
| AfricanAmerican-vs-Asian |
6.840400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.103700E-03 |
| Normal-vs-Female |
2.833900E-02 |
| Male-vs-Female |
1.757020E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.667590E-01 |
| Normal-vs-Age(41-60Yrs) |
8.400500E-04 |
| Normal-vs-Age(61-80Yrs) |
5.407900E-02 |
| Normal-vs-Age(81-100Yrs) |
3.314400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.428400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.573000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.152600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.372200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.181000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.601600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.341400E-01 |
| Classical-VS-Follicular |
1.285780E-01 |
| Classical-VS-Other |
1.409830E-01 |
| Classical-VS-Normal |
1.119000E-01 |
| Tall-VS-Follicular |
1.743410E-01 |
| Tall-VS-Other |
1.016380E-01 |
| Tall-VS-Normal |
5.552000E-01 |
| Follicular-VS-Other |
5.035800E-01 |
| Follicular-VS-Normal |
1.052100E-02 |
| Other-VS-Normal |
2.070200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.984400E-03 |
| Normal-vs-N1 |
5.165000E-03 |
| N0-vs-N1 |
3.935600E-01 |
|
|
